Orange Book product · Brand (NDA)
DIOVAN
VALSARTAN
At a glance
Dec 23, 1996
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 23, 1996
29 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
VALSARTAN
Strength
160MG
Dosage form
CAPSULE
Route
ORAL
TE code
Not listed
Application
NDA 020665
Product number
002
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a brand (NDA) product. Other products sharing this active ingredient are listed below.
- 2017PREXXARTANBrand (NDA)
NDA 209139 · CARMEL BIOSCIENCES
- 2002DIOVANBrand (NDA)
NDA 021283 · NOVARTIS
- 2026VALSARTANGeneric (ANDA)
ANDA 218897 · LAURUS
- 2025VALSARTANGeneric (ANDA)
ANDA 216460 · RUBICON RESEARCH
- 2024VALSARTANGeneric (ANDA)
ANDA 218169 · RENATA
- 2024VALSARTANGeneric (ANDA)
ANDA 218991 · ZYDUS LIFESCIENCES
- 2021VALSARTANGeneric (ANDA)
ANDA 214102 · NOVITIUM PHARMA
- 2021VALSARTANGeneric (ANDA)
ANDA 204038 · SCIEGEN PHARMS
- 2021VALSARTANGeneric (ANDA)
ANDA 201618 · DR REDDYS
- 2019VALSARTANGeneric (ANDA)
ANDA 205536 · ALKEM LABS LTD
- 2018VALSARTANGeneric (ANDA)
ANDA 209261 · UNICHEM
- 2018VALSARTANGeneric (ANDA)
ANDA 205347 · SQUARE PHARMS PLC
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
